Literature DB >> 31226653

Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Anna Egorova1, Sean Ekins2, Michaela Schmidtke3, Vadim Makarov4.   

Abstract

The hydrophobic pocket within viral capsid protein 1 is a target to combat the rhino- and enteroviruses (RV and EV) using small molecules. The highly conserved amino acids lining this pocket enable the development of antivirals with broad-spectrum of activity against numerous RVs and EVs. Inhibitor binding blocks: the attachment of the virion to the host cell membrane, viral uncoating, and/or production of infectious virus particles. Syntheses and biological studies of the most well-known antipicornaviral capsid binders have been reviewed and we propose next steps in this research.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Antivirals; Common cold; Drug design/discovery; Enterovirus; Pleconaril; Rhinovirus

Mesh:

Substances:

Year:  2019        PMID: 31226653      PMCID: PMC8194503          DOI: 10.1016/j.ejmech.2019.06.008

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  84 in total

1.  Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.

Authors:  Michaela Schmidtke; Elke Hammerschmidt; Susanne Schüler; Roland Zell; Eckhard Birch-Hirschfeld; Vadim A Makarov; Olga B Riabova; Peter Wutzler
Journal:  J Antimicrob Chemother       Date:  2005-09-08       Impact factor: 5.790

2.  A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.

Authors:  Jinwoo Kim; Yu Kyoung Jung; Chonsaeng Kim; Jin Soo Shin; Els Scheers; Joo-Youn Lee; Soo Bong Han; Chong-Kyo Lee; Johan Neyts; Jae-Du Ha; Young-Sik Jung
Journal:  J Med Chem       Date:  2017-06-15       Impact factor: 7.446

3.  Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.

Authors:  Laurène Da Costa; Els Scheers; Antonio Coluccia; Adriano Casulli; Manon Roche; Carole Di Giorgio; Johan Neyts; Thierry Terme; Roberto Cirilli; Giuseppe La Regina; Romano Silvestri; Carmen Mirabelli; Patrice Vanelle
Journal:  J Med Chem       Date:  2018-09-07       Impact factor: 7.446

4.  QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.

Authors:  Eugene N Muratov; Ekaterina V Varlamova; Anatoly G Artemenko; Tat'yana Khristova; Victor E Kuz'min; Vadim A Makarov; Olga B Riabova; Peter Wutzler; Michaela Schmidtke
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

5.  Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors.

Authors:  Kak-Shan Shia; Wen-Tai Li; Chung-Ming Chang; Ming-Chu Hsu; Jyh-Haur Chern; Max K Leong; Sung-Nien Tseng; Chung-Chi Lee; Yen-Chun Lee; Shu-Jen Chen; Kuan-Chang Peng; Huan-Yi Tseng; Yi-Ling Chang; Chia-Liang Tai; Shin-Ru Shih
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

6.  The interaction between St John's wort and an oral contraceptive.

Authors:  Stephen D Hall; Zaiqi Wang; Shiew-Mei Huang; Mitchell A Hamman; Nina Vasavada; Adegboyega Q Adigun; Janna K Hilligoss; Margaret Miller; J Christopher Gorski
Journal:  Clin Pharmacol Ther       Date:  2003-12       Impact factor: 6.875

Review 7.  Ligand- and structure-based pregnane X receptor models.

Authors:  Sandhya Kortagere; Matthew D Krasowski; Sean Ekins
Journal:  Methods Mol Biol       Date:  2012

8.  In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.

Authors:  M J Otto; M P Fox; M J Fancher; M F Kuhrt; G D Diana; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

9.  Oral efficacy of WIN 51711 in mice infected with human poliovirus.

Authors:  M A McKinlay; B A Steinberg
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR.

Authors:  Sean Ekins; Sandhya Kortagere; Manisha Iyer; Erica J Reschly; Markus A Lill; Matthew R Redinbo; Matthew D Krasowski
Journal:  PLoS Comput Biol       Date:  2009-12-11       Impact factor: 4.475

View more
  13 in total

1.  Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.

Authors:  Rami Musharrafieh; Naoya Kitamura; Yanmei Hu; Jun Wang
Journal:  Bioorg Chem       Date:  2020-06-01       Impact factor: 5.275

2.  Enterovirus D68 Antivirals: Past, Present, and Future.

Authors:  Yanmei Hu; Rami Musharrafieh; Madeleine Zheng; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-05-14       Impact factor: 5.084

3.  A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.

Authors:  Chunlong Ma; Yanmei Hu; Jiantao Zhang; Rami Musharrafieh; Jun Wang
Journal:  ACS Infect Dis       Date:  2019-09-18       Impact factor: 5.084

4.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

5.  Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.

Authors:  Anna Egorova; Elena Kazakova; Birgit Jahn; Sean Ekins; Vadim Makarov; Michaela Schmidtke
Journal:  Eur J Med Chem       Date:  2019-12-23       Impact factor: 6.514

Review 6.  Viral structural proteins as targets for antivirals.

Authors:  Christopher John Schlicksup; Adam Zlotnick
Journal:  Curr Opin Virol       Date:  2020-08-07       Impact factor: 7.090

Review 7.  Antivirals blocking entry of enteroviruses and therapeutic potential.

Authors:  Mohd Ishtiaq Anasir; Faisal Zarif; Chit Laa Poh
Journal:  J Biomed Sci       Date:  2021-01-15       Impact factor: 8.410

8.  Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts.

Authors:  Christin Walther; Kristin Döring; Michaela Schmidtke
Journal:  BMC Complement Med Ther       Date:  2020-12-23

Review 9.  Antiviral effects of azithromycin: A narrative review.

Authors:  Saeed Khoshnood; Maryam Shirani; Amine Dalir; Melika Moradi; Mohammad Hossein Haddadi; Nourkhoda Sadeghifard; Faezeh Sabet Birjandi; Ilya Yashmi; Mohsen Heidary
Journal:  Biomed Pharmacother       Date:  2022-02-04       Impact factor: 6.529

10.  Enterovirus Inhibition by Hinged Aromatic Compounds with Polynuclei.

Authors:  Jih Ru Hwu; Avijit Panja; Srinivasan Jayakumar; Shwu-Chen Tsay; Kui-Thong Tan; Wen-Chieh Huang; Yu-Chen Hu; Pieter Leyssen; Johan Neyts
Journal:  Molecules       Date:  2020-08-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.